1Cha EK, Tirsar LA, Schwentner C, et al. Immunocytology is a strong predictor of bladder cancer presence in patients with painless hematuria: a muhicentre study[J]. Eur Urol, 2012, 61(1) : 185-192.
2Xylinas E, Kluth LA, Rieken M, et al. Urine markers for de- tection and surveillance of bladder cancer[J]. Urol Oncol, 2014,32(3) : 222-229.
3Hajdinjak T. UroVysion FISH test for detecting urothelial cancers: meta-analysis of diagnostic accuracy and comparison with uri- nary cytology testing[J]. Urol Oncol,2008,26(6):646-651.
4Gofrit ON, Zorn KC, Silvestre J, et al. The predictive value of multi-targeted fluorescent in-situ hybridization in patients with history of bladder canccr[J ]. Urol Oncol, 2008,26 (3) : 246-249.
5van der Aa MN, Zwarthoff EC, Steyerberg EW, et al. Micro- satellite analysis of voided-urine samples for surveillance oflow-grade non-muscle-invasiveurothelial carcinoma: feasibility and c!.inical utility in a prospective multicenter study (Cost- Effectiveness of Follow-Up of Urinary Bladder Cancer trial ECEFUB)[J]. Eur Urol,2009,55(3) :659-667.
6Roupr:t M, Hupertan V, Yates DR, et al. A comparison of the performance of microsatellite and methylation urine analy- sis for predicting the recurrence of urothelial cell carcinoma, and definition of a set of markers by Bayesian network analy- sis[J]. BJU Int,2008,101(11) :1448-1453.
7Luzar B, Poljak M, Marin IJ, et al. Quantitative measure ment of telomerase catalytic subunit (hTERT) mRNA in la ryngeal squamous cell carcinomas[J]. Anticancer Res, 2001, 21(6A) :4011-4015.
8Park HS, Park WS, Bondaruk J, et al. Quantitation of Auro- ra kinase A gene copy number in urine sediments and bladder cancer detection[J]. J Natl Cancer Inst, 2008,100 (19) : 1401- 1411.
9Lokeshwar VB, Habuchi T, Grossman HB, et al. Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers[J]. Urology, 2005, 66 (6 Suppl 1) :35-63.
10Konety BR, Getzenberg RH. Urine based markers of urologi- cal malignancy[J]. J Urol,2001,165(2):600-611.
